FILE PHOTO: Picture illustration of a UnitedHealth Group health insurance card in a wallet (Reuters) -UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products ...
The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...
ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A screen displays the logo for Cigna Corp. on the floor at the NYSE in New York (Reuters) - Cigna Corp's pharmacy ...
The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. announced on December 15 that BASAGLAR (insulin glargine injection 100 units/mL) is available by prescription in ...
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration has approved changes to the prescribing information for its Afrezza inhaled ...
Hy-Vee is lending a hand to diabetes patients not covered by Medicare who seek lower-cost insulin. West Des Moines, Iowa-based Hy-Vee said Thursday that it has launched an insulin savings website that ...
The protocol was evaluated for the first 30 patients. Data were collected from September 2003 to August 2004. When a patient was started on the protocol, the pharmacy clinical coordinator and the ...
Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results